Sharechat Logo

Strategic Finance suspends redemptions

Thursday 7th August 2008

Text too small?
Strategic Finance, whose managers and directors are seeking to buy out the firm, today suspended redemptions of debentures and notes citing dwindling liquidity.

"While negotiations have been continuing there has been a further material decline in the property finance market sector and reinvestment rates," chief executive Kerry Finnigan said in a statement.

Managers led by Finnigan teamed up with Halifax Bank of Scotland unit BOS International to acquire the company, gaining support from BOS for a NZ$150 million wholesale lending facility that would reduce its need for debenture funds. Those talks may result in a capital restructure as well as a change of ownership, the company said today.

The proposal is subject to approval by shareholders of Allco HIT Ltd., which is selling Strategic Finance's immediately parent. Strategic's current owners are "unable to assist in providing the necessary capital we need to run the business and move forward," Finnigan told BusinessWire last month.

The company had assets of NZ$568 million at June 30, with debentures at NZ$320 million. Strategic's 10.52% perpetual preference shares trade on the NZX debt market.

From today the company also has stopped accepting subscriptions for debentures and subordinated notes, it said.

By Jonathan Underhill



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report